Skip to main content
Full access
Communications and Updates
Published Online: 1 February 2013

A New Stimulant of Abuse: 5-(2-aminopropyl)indole

To the Editor: In recent years, an increasing demand for legal substances of abuse that mimic the effects of traditional and illicit drugs has resulted in the appearance of several new compounds in the recreational drug market. These new substances, generally marketed as “legal highs,” are synthetic products and vegetable derivatives sold online or in specialized street shops known as “head” or “smart” shops. In particular, many research compounds, generally marketed by specialized suppliers and labeled “not for human consumption,” have become popular among drug users for their strong psychotropic effects. The growing phenomenon of legal highs has resulted in numerous confirmed cases of severe intoxication and fatalities related to the consumption of new recreational drugs in many countries. A potential recreational drug of abuse named 5-(2-aminopropyl)indole (also known as 5-API or 5-IT) has been recently flagged in Sweden. In 2012, the Swedish Poisons Information Center reported several cases of severe intoxication related to the consumption of 5-IT. In addition, the National Laboratory of Forensic Toxicology has analytically confirmed the presence of 5-IT in 14 postmortem examinations. The postmortem blood concentration range was between 0.7 and 5.2 µg/g in 10 cases; no quantitative data were reported in the other four cases. The femoral blood concentration was 18.6 µg/g in one individual, and 5-IT was the single substance found and was identified as the cause of death in two others (1). Furthermore, 5-IT was found in combination with other drugs in postmortem blood samples of two young adults in the United Kingdom (2).
5-IT is a little-known 5-positional isomer of α-methyltryptamine, a synthetic indole analog of amphetamine. This molecule shows a bicyclic structure consisting of a six-membered benzene ring fused with a five-membered nitrogen-containing pyrrole ring, and it is considered the only psychoactive α-methyltryptamine positional isomer (3). To our knowledge, no formal study has investigated the pharmacological and toxicological properties of this substance. Users have reported that the desired effects include mild euphoria, mood enhancement, greater sociability and energy, and intensification of sensory experience. Users have also reported untoward effects such as anxiety, psychomotor agitation, confusion, insomnia, sweating, restlessness, tremors, jaw clenching, dilated pupils, and increases in heart rate, blood pressure, and body temperature. 5-IT is generally consumed intranasally or orally, and the dosage range reported by users is between 50 mg and 120 mg. The onset of action occurs within 30 minutes to 1 hour of ingestion, and the effects may last up to 10 hours (1, 4).
In conclusion, 5-IT appears to be a strong stimulant producing amphetamine-like effects. International cooperation is of great importance in monitoring and preventing the spread of this dangerous recreational substance.

References

1.
Belgian Early Warning System on Drugs (BEWSD): 5-IT deaths in Sweden, 2012. http://ewsd.wiv-isp.be/Main/5-IT%20deaths%20in%20Sweden.aspx
2.
Seetohul LN, Maskell PD, De Paoli G, Pounder DJ: Deaths associated with new designer drug 5-IT. BMJ 2012; 345:e5625
4.
ReDNet Research Group: 5-IT full report. London, Institute of Psychiatry, King’s College London, 2012 (https://www.rednetproject.eu/groups/5it/)

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 226
PubMed: 23377642

History

Accepted: December 2012
Published online: 1 February 2013
Published in print: February 2013

Authors

Affiliations

M. Coppola, M.D.
From the Department of Addiction, ASL CN2, Viale Coppino 46, Alba, Italy, and the Department of Mental Health, ASL CN1, Via Torino 70/B, Saluzzo, Italy.
R. Mondola, M.D.
From the Department of Addiction, ASL CN2, Viale Coppino 46, Alba, Italy, and the Department of Mental Health, ASL CN1, Via Torino 70/B, Saluzzo, Italy.

Competing Interests

The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share